NCT01741792 2017-01-06Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Amgen Research (Munich) GmbHPhase 2 Completed25 enrolled 18 charts